Explorative, Double-blind, Randomized, Controlled Multi-center Phase II Study to Evaluate the Efficacy and Safety of Topically Applied LAS41003 Once Daily Versus LAS189962 and LAS189961 in the Treatment of Superficial Infected Eczema.
Phase of Trial: Phase II
Latest Information Update: 14 May 2014
At a glance
- Drugs Octenidine/prednicarbate (Primary) ; Octenidine; Prednicarbate
- Indications Eczema
- Focus Therapeutic Use
- Sponsors Almirall S.A.
- 14 May 2014 New trial record